News

FDA grants rezafungin QIDP and fast track designations
- Author:
- HT Staff
The U.S.
News

Factors that may drive relapse in AYAs with ALL
- Author:
- HT Staff
New research suggests race, clinical trial participation, and treatment duration may influence the risk of relapse in adolescents and young adults...
News

Study supports immediate compression after DVT
- Author:
- HT Staff
Immediate compression therapy provides a “clear benefit” for patients with deep vein thrombosis (DVT), according to the senior author of a study...
News

Placenta-derived product receives orphan designation for HSCT
- Author:
- HT Staff
The U.S.
News

FDA lifts partial hold on tazemetostat trials
- Author:
- HT Staff
The U.S.
News

Blinatumomab approved to treat ALL in Japan
- Author:
- HT Staff
The Japanese Ministry of Health, Labour and Welfare has approved blinatumomab (Blincyto®) for the treatment of relapsed or refractory B-cell acute...
News

FDA approves duvelisib for CLL/SLL and FL
- Author:
- HT Staff
The U.S.
News

FLT3 inhibitor approved for rel/ref AML in Japan
- Author:
- HT Staff
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the FLT3 inhibitor gilteritinib (Xospata®) to treat patients with FLT3-...
News

Drug approved as part of frontline therapy for HL
- Author:
- HT Staff
The Japanese Ministry of Health, Labour and Welfare has approved brentuximab vedotin (Adcetris) in combination with doxorubicin, vinblastine, and...
News

Product approved to treat hemophilia A in Japan
- Author:
- HT Staff
The Japanese Ministry of Health, Labour and Welfare has approved Jivi® (also known as damoctocog alfa pegol or antihemophilic factor [recombinant...
News

CHMP reconsiders new indication for blinatumomab
- Author:
- HT Staff
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) said it will re-examine a recent opinion on blinatumomab (...
News

CHMP backs proposed biosimilars of pegfilgrastim
- Author:
- HT Staff
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for three proposed biosimilars of...
News

CHMP recommends factor VIII therapy for hemophilia A
- Author:
- HT Staff
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for damoctocog alfa pegol, a...
News

CHMP supports new indication for venetoclax
- Author:
- HT Staff
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) approve a...
News

CHMP recommends mogamulizumab for MF, SS
- Author:
- HT Staff
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for mogamulizumab (Poteligeo)....